- Home
- OMH vs AIDX Comparison
OMH vs AIDX Comparison
Compare OMH & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OMH | AIDX |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 4.9M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | OMH | AIDX |
|---|---|---|
| Price | $3.14 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 75.0K | ★ 113.9K |
| Earning Date | 11-27-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,045,133.00 |
| Revenue This Year | $39.14 | $44.20 |
| Revenue Next Year | $145.74 | $95.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.06 | $0.25 |
| 52 Week High | $3.75 | $18.96 |
Technical Indicators
Market Signals| Indicator | OMH | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 66.11 | 23.07 |
| Support Level | $2.17 | N/A |
| Resistance Level | $3.75 | $0.69 |
| Average True Range (ATR) | 0.29 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 62.33 | 1.70 |
Price Performance
Historical ComparisonAbout OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.